Core Insights - Yidu Technology (2158.HK) reported a total revenue of RMB 358.1 million for the six months ending September 30, 2025, representing an 8.7% year-on-year growth, with losses significantly narrowing by 72%, nearing breakeven [1] - The revenue growth was primarily driven by favorable policies that stimulated market demand, leading to a substantial increase in order volume [1] - The company effectively controlled operating costs through continuous optimization of internal operations and enhanced collaboration across business segments, improving resource utilization efficiency [1] - Cash outflow from operating activities decreased by 56% year-on-year, maintaining a robust cash reserve to seize future market opportunities and achieve high-quality growth [1] - Yidu Technology's AI technology made significant advancements, with its "AI Medical Brain" YiduCore processing and analyzing over 1.3 billion patient visits and nearly 7 billion authorized medical records, covering all known diseases in its disease knowledge graph and expanding its specialized disease database to 98 categories [1] Business Operations - Yidu Technology's large model innovation has been fully implemented across the "medical, pharmaceutical, insurance, and patient" scenarios [2] - The company has served 127 well-known hospitals, covering over 10,000 hospitals, with the "Doctor Copilot" being called nearly 1,000 times daily in a single hospital, reaching approximately 70% of healthcare personnel [2] - Collaborations with leading experts in fields such as cervical cancer, weight loss, and liver cancer have led to the development of a "digital twin" for doctors, enhancing patient service and refined management [2]
医渡科技2026财年中期业绩：AI应用加速，几近盈亏平衡